Abbott (ABT)

• Market cap: $192B
• 1 day: -1.80%
• 5 days: -2.45%
• 1 month: -1.46%
• 3 months: -4.37%
• 6 months: 7.79%
• Year to date: -2.17%
• 1 year: -2.44%
• 5 years: 27.01%
• 10 years: 152.51%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

About: Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

Employees: 114,000

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

47% more first-time investments, than exits

New positions opened: 187 | Existing positions closed: 127

9% more funds holding in top 10

Funds holding in top 10: 58 [Q2] → 63 (+5) [Q3]

5% more capital invested

Capital invested by funds: $143B [Q2] → $150B (+$7.71B) [Q3]

4% more call options, than puts

Call options by funds: $1.1B | Put options by funds: $1.05B

1% more funds holding

Funds holding: 2,813 [Q2] → 2,837 (+24) [Q3]

3.15% less ownership

Funds ownership: 78.76% [Q2] → 75.6% (-3.15%) [Q3]

11% less repeat investments, than reductions

Existing positions increased: 1,049 | Existing positions reduced: 1,178

Research analyst outlook

7 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $117 5% upside
• Avg. target: $134 21% upside
• High target: $149 34% upside

7 analyst ratings

• positive: 4 57%
• neutral: 3 43%
• negative: 0 0%

Barclays Matt Miksic 68% 1-year accuracy 25 / 37 met price target	34% upside $149	Overweight Maintained	5 Nov 2024
Bernstein Lee Hambright 67% 1-year accuracy 4 / 6 met price target	24% upside $138	Outperform Maintained	17 Oct 2024
UBS Danielle Antalffy 38% 1-year accuracy 5 / 13 met price target	32% upside $146	Buy Maintained	17 Oct 2024
Jefferies Matthew Taylor 40% 1-year accuracy 2 / 5 met price target	13% upside $125	Hold Maintained	17 Oct 2024
Mizuho Anthony Petrone 42% 1-year accuracy 16 / 38 met price target	17% upside $130	Neutral Maintained	17 Oct 2024